BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xing Y, Li B, He J, Hua H. Labial Gland Mesenchymal Stem Cell Derived Exosomes-Mediated miRNA-125b Attenuates Experimental Sjogren's Syndrome by Targeting PRDM1 and Suppressing Plasma Cells. Front Immunol 2022;13:871096. [PMID: 35444638 DOI: 10.3389/fimmu.2022.871096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Fang Y, Ni J, Wang YS, Zhao Y, Jiang LQ, Chen C, Zhang RD, Fang X, Wang P, Pan HF. Exosomes as biomarkers and therapeutic delivery for autoimmune diseases: Opportunities and challenges. Autoimmun Rev 2022;22:103260. [PMID: 36565798 DOI: 10.1016/j.autrev.2022.103260] [Reference Citation Analysis]
2 Harrell CR, Djonov V, Volarevic V. Therapeutic Potential of Mesenchymal Stem Cells in the Treatment of Ocular Graft-Versus-Host Disease. IJMS 2022;23:13254. [DOI: 10.3390/ijms232113254] [Reference Citation Analysis]
3 Tan Z, Wang L, Li X. Composition and regulation of the immune microenvironment of salivary gland in Sjögren’s syndrome. Front Immunol 2022;13:967304. [DOI: 10.3389/fimmu.2022.967304] [Reference Citation Analysis]